Product Images Dexmethylphenidate Hydrochloride

This is a description of prescription medication with the National Drug Code (NDC) 49884-546-01. It is an extended-release capsule containing 40 mg of Dexmethylphenidate hydrochloride, used to treat attention deficit hyperactivity disorder (ADHD). The usual dosage instructions for this medication can be found in the package insert. It is important to keep this medication and all drugs in a secure place out of reach of children. This medication guide provided by the pharmacy should be read carefully before use. It must be dispensed in a tight container (USP) and stored at room temperature (20° to 25°C) and excursions are permitted to 15° to 30°C.*

This is a description of Dexmethylphenidate HCI Extended-Release Capsules with NDC code 49834-048-01. Each capsule contains 5 mg of dexmethylphenidate hydrochloride, and the usual dosage instructions can be found in the package insert. Pharmacists can dispense this medication in a tight container, and it should be stored at 20° to 25°C (68° to 77°F), with allowances for excursions to 15° to 30°C (59° to 86°F). The manufacturing company is Par Pharmaceutical in Chestnut Ridge, NY.*

This is a medication called Dexmethylphenidate HCI, which is available in extended-release capsules containing 10mg of the medicine. The usual dosage is not mentioned and one should refer to the package insert for it. The medication should be kept out of reach of children and stored in a tight container at a temperature ranging from 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F) in compliance with USP Controlled Room Temperature. The medication has been manufactured by Par Pharmaceutical located in Chestnut Ridge, NY 10977.*

This is a medication with the NDC code 49884-090-01, containing 100 extended-release capsules of 15mg dexmethylphenidate hydrochloride. It is dispensed with a medication guide and should be kept out of reach of children. The usual dosage can be found in the package insert, and it must be stored in a tight container at 20-25°C with excursions permitted to 15-30°C. The medication was manufactured by Par Pharmaceutical in Chestnut Ridge, NY.*

This is a medication containing Dexmethylphenidate HCI, available in the form of extended-release capsules. Each capsule contains 20 mg of dexmethylphenidate hydrochloride. The dosage is mentioned in the package insert. The medication comes in a tight container and should be stored at 20° to 25°C, with excursions permitted to 15° to 30°C. The manufacturing company is Par Pharmaceutical. This medication requires a prescription and should be kept away from children.*

This text appears to be a medication label. The medication is an extended-release capsule containing 25 mg of dexmethylphenidate hydrochloride, a drug used to treat attention deficit hyperactivity disorder (ADHD). The label includes dosage instructions, storage recommendations, and a precautionary statement to keep the medication out of the reach of children. The Rx onl suggests that this drug is prescription-only.*

Each capsule of NDC 49884-539-01 is an extended-release medication that includes 30mg of methylphenidate hydrochloride. Follow the given dosage guidelines provided in the package. Store this medication in a tight container at room temperature, away from children's reach. A medication guide is provided separately to dispense each patient.*

This is a description for a drug called Dexmethylphenidate Hcl which comes in an extended-release capsule containing 35 mg of dexmethylphenidate hydrochloride. The usual dosage is mentioned in the package insert. The drug should be kept out of reach of children and dispensed in a tight container while being stored at a temperature between 20°C to 25°C. It is available in a pack of 100 capsules.*